You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 050536

✉ Email this page to a colleague

« Back to Dashboard

NDA 050536 describes ERYC, which is a drug marketed by Dr Reddys Labs Sa, Parke Davis, Warner Chilcott Llc, Hospira, and Johnson And Johnson, and is included in seven NDAs. It is available from one supplier. Additional details are available on the ERYC profile page.

The generic ingredient in ERYC is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the erythromycin profile page.

Summary for 050536

Tradename:	ERYC
Applicant:	Dr Reddys Labs Sa
Ingredient:	erythromycin
Patents:	0

Medical Subject Heading (MeSH) Categories for 050536

Anti-Bacterial Agents
Gastrointestinal Agents
Protein Synthesis Inhibitors

Suppliers and Packaging for NDA: 050536

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
ERYC	erythromycin	CAPSULE, DELAYED REL PELLETS;ORAL	050536	NDA AUTHORIZED GENERIC	Dr. Reddy's Labratories Inc.	75907-076	75907-076-01	100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (75907-076-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE, DELAYED REL PELLETS;ORAL			Strength	250MG
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.